Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

mizolastine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Abstract Absorption, distribution, metabolism and excretion of desloratadine, fexofenadine, levocetirizine, and mizolastine in… Expand
Is this relevant?
Review
2004
Review
2004
Chronic urticaria is a common condition that can be very disabling when severe. A cause for chronic idiopathic urticaria (CIU) is… Expand
Is this relevant?
2004
2004
Mizolastine is a second generation antihistamine agent approved in Europe for the treatment of allergic rhinitis and skin… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table III
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Levocetirizine is the active enantiomer of cetirizine, a potent drug with little metabolism widely used for allergic… Expand
Is this relevant?
Review
2001
Review
2001
Mizolastine is a new histamine H1 receptor antagonist. Mizolastine 10 mg/day is effective in allergic rhinitis and chronic… Expand
Is this relevant?
2000
2000
1. Ventricular arrhythmias are rare but life-threatening side effects of therapy with the second-generation H(1) receptor… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND A role of potential histamine-releasing autoantibodies against the high-affinity IgE receptor on the surface of… Expand
Is this relevant?
1996
1996
A two-centre, double-blind, randomized, placebo (P)-controlled, parallel-group study was conducted in the UK to examine the… Expand
Is this relevant?
1995
1995
The pharmacodynamic interaction between mizolastine, a new H1 antihistamine, and ethanol was assessed in a randomized, double… Expand
  • table 1
  • table 2
  • figure 2
Is this relevant?
1994
1994
Eighteen healthy volunteers received mizolastine 5 mg, 15 mg or 45 mg, terfenadine 60 mg, triprolidine 10 mg or placebo in a 6… Expand
  • table 1
Is this relevant?